↓ Skip to main content
What is this page? Embed badge

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study…

Overview of attention for article published in RMD Open, February 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#27 of 1,202)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
13 news outlets
twitter
6 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
18 Mendeley
Summary News X Dimensions citations

This page is provided by Altmetric.